24th January 2022
$2.8m MRFF boost for vital cancer immunotherapy research
Mater Research will begin trialing a new targeted immunotherapy in 2022 to treat a rare but devastating blood cancer thanks to a $2.8m grant
Latest News
22 March 2021
Research collaboration changes understanding of Alzheimer’s disease
Alzheimer's disease breakthrough
More about Research collaboration changes understanding of Alzheimer’s disease
2 March 2021
Discovery of new type of bone cell gives hope for osteoporosis
TRI-based UQDI scientists part of a groundbreaking bone cell study
More about Discovery of new type of bone cell gives hope for osteoporosis 
12 February 2021
Blood biomarker detects COVID-19 severity
A rapid, new blood test for COVID-19 is being commercialised.
More about Blood biomarker detects COVID-19 severity
12 February 2021
Creating predictive tools for lung cancer and COVID-19
QUT's TRI-based Dr Arutha Kulasinghe is developing new prognostic tests for cancers and COVID-19.
More about Creating predictive tools for lung cancer and COVID-19
23 November 2020
Genetic testing education could accelerate its potential
Dr Aideen McInerey-Leo finds public has low level of understanding of genetic testing
More about Genetic testing education could accelerate its potential
23 November 2020
Skin cancer treatment aims to help transplant patients
A new medication could help prevent organ transplant recipients from developing harmful skin cancers.
More about Skin cancer treatment aims to help transplant patientsPages
Events
21 March 2022 9:30 AM – 6:00 PM
ASSC Genetics Summit 21 March 2022
The Australian Skin and Skin Cancer Research Centre (ASSC) is hosting the Genetics Summit
More about ASSC Genetics Summit 21 March 2022 Upcoming Events
Sorry, no results found
Please try again with less restrictive search criteria
